ArriVent BioPharma, Inc. is in its Mercury mahadasha (26 Jan 2024 to 4 Dec 2034), Mars antardasha (4 Jun 2026 to 1 Jun 2027) and Saturn pratyantar (6 Oct 2026 to 2 Dec 2026).
Next: pratyantar Mercury from 2 Dec 2026; antardasha Rahu from 1 Jun 2027; mahadasha Ketu from 4 Dec 2034.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Makara (Capricorn) | 11°56′ | 11th | Shravana 1 |
| Moon | Karka (Cancer) | 21°29′ | 5th | Ashlesha 2 |
| Mars | Dhanu (Sagittarius) | 22°21′ | 10th | Purva Ashadha 3 |
| Mercury | Dhanu (Sagittarius) | 21°41′ | 10th | Purva Ashadha 3 |
| Jupiter | Mesha (Aries) | 12°35′ | 2nd | Ashwini 4 |
| Venus | Dhanu (Sagittarius) | 9°48′ | 10th | Mula 3 |
| Saturn | Kumbha (Aquarius) | 11°39′ | 12th | Shatabhisha 2 |
| Rahu | Meena (Pisces) | 25°21′ | 1st | Revati 3 |
| Ketu | Kanya (Virgo) | 25°21′ | 7th | Chitra 1 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how AVBP moved in each period against the S&P 500, transits, fundamentals and news.